A punctal plug implant configured to be disposed within the lacrimal canaliculus of an eye. The implant contains a drug core that comprises a silicone matrix containing monodispersed liquid latanoprost inclusions having a uniform size to form a solid drug matrix, and the latanoporst is at least 20 percent (by weight) of the drug core.